ESMO Open

Published by: European Society for Medical Oncology  

People

  1. Abou-Alfa
    Abou-Alfa
  2. Antonescu
    Antonescu
  3. Maki
    Maki
  4. Modi
    Modi
  5. O'Reilly
    O'Reilly
  6. Park
    Park
  7. Perales
    Perales
  8. Tap
    Tap
  9. Yaeger
    Yaeger

Groups

  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (4)
  3. Center for Hematologic Malignancies (2)
  4. Gastrointestinal Oncology Service (2)
  5. Hematologic Malignancies, Division of (2)
  6. Adult Leukemia (1)
  7. Bone Marrow Transplant (1)
  8. Breast Medicine Service (1)
  9. Center for Pancreatic Cancer Research (1)
  10. Department of Pathology and Laboratory Medicine (1)
Search Within
  1. "Review"
Formats
  1. Review (8)
Groups
  1. Department of Medicine (6)
  2. Solid Tumor Oncology Division (4)
  3. Center for Hematologic Malignancies (2)
  4. Gastrointestinal Oncology Service (2)
  5. Hematologic Malignancies, Division of (2)
  6. Adult Leukemia (1)

More Groups

People
  1. Ana Alarcon Tomas (1)
  2. Cristina Antonescu (1)
  3. Eileen O'Reilly (1)
  4. Ghassan Abou-Alfa (1)
  5. Jae Park (1)
  6. Miguel-Angel Perales (1)

More People

Years
  1. 2024 (3)
  2. 2023 (1)
  3. 2021 (2)
  4. 2020 (2)
Publishers
  1. European Society for Medical Oncology (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Current unmet needs in locally advanced (unresectable) or metastatic dedifferentiated liposarcoma, the relevance of progression-free survival as clinical endpoint, and expectations for future clinical trial design: An international Delphi consensus report
    Review

    Schöffski, P.; Jones, R. L.; Agulnik, M.; Blay, J. Y.; Chalmers, A.; Italiano, A.; Pink, D.; Stacchiotti, S.; Valverde, C.; Vincenzi, B.; more...
    ESMO Open (2024)

    Fulltext@MSK | Save
  • Open questions, current challenges, and future perspectives in targeting human epidermal growth factor receptor 2-low breast cancer
    Review

    Curigliano, G.; Dent, R.; Earle, H.; Modi, S.; Tarantino, P.; Viale, G.; Tolaney, S. M.
    ESMO Open (2024)

    Fulltext@MSK | Save
  • Policy strategies for capacity building and scale up of the workforce for comprehensive cancer care: A systematic review
    Review

    Trapani, D.; Murthy, S. S.; Hammad, N.; Casolino, R.; Moreira, D. C.; Roitberg, F.; Blay, J. Y.; Curigliano, G.; Ilbawi, A. M.
    ESMO Open (2024)

    Fulltext@MSK | Save
  • The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
    Review

    Ducreux, M.; Abou-Alfa, G. K.; Bekaii-Saab, T.; Berlin, J.; Cervantes, A.; de Baere, T.; Eng, C.; Galle, P.; Gill, S.; Gruenberger, T.; more...
    ESMO Open (2023)

    Fulltext@MSK | Save
  • Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: Insights from the BEACON CRC study
    Review

    Tabernero, J.; Velez, L.; Trevino, T. L.; Grothey, A.; Yaeger, R.; Van Cutsem, E.; Wasan, H.; Desai, J.; Ciardiello, F.; Yoshino, T.; more...
    ESMO Open (2021)

    Fulltext@MSK | Save
  • Epithelioid hemangioendothelioma, an ultra-rare cancer: A consensus paper from the community of experts
    Review

    Stacchiotti, S.; Miah, A. B.; Frezza, A. M.; Messiou, C.; Morosi, C.; Caraceni, A.; Antonescu, C. R.; Bajpai, J.; Baldini, E.; Bauer, S.; more...
    ESMO Open (2021)

    Fulltext@MSK | Save
  • Managing toxicities with asparaginase-based therapies in adult all: Summary of an ESMO Open-Cancer Horizons roundtable discussion
    Review

    Burke, P. W.; Hoelzer, D.; Park, J. H.; Schmiegelow, K.; Douer, D.
    ESMO Open (2020)

    Fulltext@MSK | Save
  • How I treat adverse effects of CAR-T cell therapy
    Review

    Yáñez, L.; Alarcón, A.; Sánchez-Escamilla, M.; Perales, M. A.
    ESMO Open (2020)

    Fulltext@MSK | Save

    • ESMO Open – authorized name for:

    Name ISSN / ISBN Publisher
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 20597029 The Authors
    ESMO Open 20597029 Unknown
    ESMO Open 20597029 The Pfizer, The Author(s)
    ESMO Open 2059-7029 Elsevier Inc.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 20597029 The Author(s)
    ESMO Open 2059-7029 European Society for Medical Oncology
    ESMO Open 2059-7029 European Society for Medical Oncology
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 20597029 European Society for Medical Oncology
    ESMO Open 20597029 Kura Oncology, Inc., The Author(s)
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 European Society for Medical Oncology
    ESMO Open 20597029 2022
    ESMO Open 2059-7029 BMJ Publishing Group Ltd.
    ESMO Open 2059-7029 BMJ Group
    ESMO Open 2059-7029 BMJ Group